Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (271-280 of 295) with videos related to

Pageof 30
Sort By:
Circulation|August 30, 2021
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C Smits, Enrico Frigoli, Jan Tijssen, et al.
Journal of the American College of Cardiology|September 22, 2022
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskPieter C Smits, Enrico Frigoli, Pascal Vranckx, et al.
Developmental Cell|December 15, 2012
The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood compositionRadu V Stan, Dan Tse, Sophie J Deharvengt, et al.
Lancet (London, England)|September 7, 2013
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trialsGiulio G Stefanini, Usman Baber, Stephan Windecker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 11, 2017
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudyTaku Asano, Yuki Katagiri, Carlos Collet, et al.
Lancet (London, England)|March 5, 2019
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trialAzfar Zaman, Robbert J de Winter, Norihiro Kogame, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
Heliyon|October 21, 2024
Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trialFrans B Mensink, Jonathan Los, Rohit M Oemrawsingh, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
JAMA Cardiology|June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Rafael Harari, Usman Baber, et al.
Pageof 30

Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
Circulation|August 30, 2021
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C Smits, Enrico Frigoli, Jan Tijssen, et al.
Journal of the American College of Cardiology|September 22, 2022
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskPieter C Smits, Enrico Frigoli, Pascal Vranckx, et al.
Developmental Cell|December 15, 2012
The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood compositionRadu V Stan, Dan Tse, Sophie J Deharvengt, et al.
Lancet (London, England)|September 7, 2013
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trialsGiulio G Stefanini, Usman Baber, Stephan Windecker, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 11, 2017
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudyTaku Asano, Yuki Katagiri, Carlos Collet, et al.
Lancet (London, England)|March 5, 2019
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trialAzfar Zaman, Robbert J de Winter, Norihiro Kogame, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCIAlessandro Spirito, Dipti Itchhaporia, Samantha Sartori, et al.
Heliyon|October 21, 2024
Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trialFrans B Mensink, Jonathan Los, Rohit M Oemrawsingh, et al.
The New England Journal of Medicine|August 27, 2021
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Enrico Frigoli, Dik Heg, et al.
JAMA Cardiology|June 29, 2017
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) CollaborationGennaro Giustino, Rafael Harari, Usman Baber, et al.
Pageof 30